Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-03-06 @ 10:57 AM
Study NCT ID:
NCT02483260
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-06-27
First Post:
2015-06-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever
Sponsor:
U.S. Army Medical Research and Development Command
Organization:
Organization Data
Organization:
Class:
FED
Study ID:
S-13-08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
FED
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None